MU
TMO icon

Mirova US’s Thermo Fisher Scientific TMO Stock Holding History

Mirova US’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296M Sell
591,257
-23,833
-4% -$11.4M 3.19% 13
2026
Q1 		$302M Sell
615,090
-26,169
-4% -$14.2M 3.43% 13
2025
Q4 		$372M Sell
641,259
-19,530
-3% -$11M 3.73% 9
2025
Q3 		$320M Sell
660,789
-26,277
-4% -$12.2M 3.24% 12
2025
Q2 		$279M Sell
687,066
-101,873
-13% -$42.6M 2.88% 15
2025
Q1 		$393M Buy
788,939
+26,414
+3% +$14.3M 4.66% 8
2024
Q4 		$397M Sell
762,525
-23,283
-3% -$12.8M 4.76% 7
2024
Q3 		$486M Buy
785,808
+4,800
+0.6% +$2.84M 5.58% 6
2024
Q2 		$432M Buy
781,008
+16,189
+2% +$9.27M 5.38% 7
2024
Q1 		$445M Sell
764,819
-13,615
-2% -$7.64M 5.98% 7
2023
Q4 		$413M Sell
778,434
-5,018
-0.6% -$2.43M 6.23% 5
2023
Q3 		$397M Buy
783,452
+29,297
+4% +$15.6M 6.72% 6
2023
Q2 		$393M Buy
754,155
+16,299
+2% +$8.8M 6.55% 5
2023
Q1 		$425M Buy
737,856
+9,747
+1% +$5.49M 7.72% 3
2022
Q4 		$401M Buy
728,109
+16,405
+2% +$8.69M 8.06% 1
2022
Q3 		$361M Sell
711,704
-5,932
-0.8% -$3.32M 8.43% 1
2022
Q2 		$390M Buy
717,636
+42,260
+6% +$23.3M 8.4% 1
2022
Q1 		$399M Buy
675,376
+50,729
+8% +$29.1M 7.66% 3
2021
Q4 		$417M Buy
624,647
+65,960
+12% +$41.2M 7.83% 2
2021
Q3 		$319M Buy
558,687
+60,738
+12% +$33.3M 7.45% 3
2021
Q2 		$251M Buy
497,949
+56,253
+13% +$26.5M 6.74% 4
2021
Q1 		$202M Buy
441,696
+68,002
+18% +$32.5M 7.02% 5
2020
Q4 		$174M Buy
373,694
+3,168
+0.9% +$1.49M 7.59% 4
2020
Q3 		$164M Buy
370,526
+98,307
+36% +$40.6M 9.36% 1
2020
Q2 		$98.6M Buy
272,219
+23,265
+9% +$7.8M 8.6% 3
2020
Q1 		$70.6M Buy
248,954
+45,181
+22% +$14.2M 9.35% 2
2019
Q4 		$66.2M Buy
+203,773
New +$61.8M 8.97% 3

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mirova US's TMO Position: Q2 2026 in Review

Mirova US reduced its Thermo Fisher Scientific (TMO) stake by 3.9% in Q2 2026, selling an estimated $11.4M and leaving 591,257 shares worth $296M. The position accounts for 3.19% of the portfolio, ranked #13.

Mirova US first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $486M in Q3 2024. 2,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mirova US held 591,257 shares of Thermo Fisher Scientific worth $296M as of Q2 2026.
  • Mirova US sold 23,833 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.4M.
  • Thermo Fisher Scientific made up 3.19% of Mirova US's portfolio in Q2 2026, its #13 holding.
  • Mirova US first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Mirova US's Thermo Fisher Scientific position peaked at $486M in Q3 2024.
  • 2,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mirova US's 13F filing for Q2 2026, filed 14 Aug 2026.